<DOC>
	<DOCNO>NCT02261051</DOCNO>
	<brief_summary>Symptom Management , Quality Life Satisfaction Care Advanced Stage Cancers first part two part study ( The Lancaster Cancer Care Model ( LCCM ) - Non-Concurrent Control Study ) . The primary aim study compare proportion advance cancer patient hospitalization emergency department visit last 6 month life implementation new care model provide comprehensive symptom management supportive care , include earlier referral palliative care . The secondary comparative aim ass measure quality life satisfaction group . This current study collect data control group . After system redesign , open intervention arm study collect data implementation new care model ( 18-24 month start control phase ) .</brief_summary>
	<brief_title>Symptom Management , Quality Life Satisfaction With Care Advanced Stage Cancers - Control Arm</brief_title>
	<detailed_description>Symptom Management , Quality Life Satisfaction Care Advanced Stage Cancers first part two part study ( The Lancaster Cancer Care Model ( LCCM ) - Non-Concurrent Control Study ) submit National Cancer Institute ( NCI ) funding . A decision funding full study forthcoming early part 2015 . The primary aim study compare proportion advance cancer patient hospitalization emergency department visit last 6 month life implementation new care model provide comprehensive symptom management supportive care , include earlier referral palliative care . The secondary comparative aim ass measure quality life satisfaction group . To accomplish aim study end funding period , propose begin data collection advance funding decision . Should study receive funding , data collect used inform decision regard funding application and/or implementation program change Ann B. Barshinger Cancer Institute . Data collection represent minimal risk patient enrol . This protocol first phase study , enrollment collection data control group , serve baseline comparison regard hospitalization , ED visit , quality life , patient family satisfaction . To achieve sufficient number subject observed death control group , target start enrollment data collection group third quarter 2014 . If project fund , intervention enrollment intervention group target start second quarter 2016 . Background study aim present entire project provide context , intent application approval enrollment data collection control subject ( contributes aim 2 3 large project ) . A second protocol would present review approval start intervention project funding grant . In phase one project , subject would approach consented point determination/diagnosis advance cancer follow end life start intervention period 2nd quarter 2016 ( whichever come first ) per protocol . This current study collect data control group . After system redesign , open intervention arm study collect data implementation new care model ( 18-24 month start control phase ) .</detailed_description>
	<criteria>Newly diagnose solid tumortype cancer consider either advanced unresectable metastatic NonEnglish speaking Age &lt; 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Palliative Care</keyword>
	<keyword>Hospice</keyword>
	<keyword>End Life</keyword>
	<keyword>Health Service Utilization</keyword>
	<keyword>Quality Life</keyword>
</DOC>